Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 132449-89-9, Lesopitron (dihydrochloride), E-4424, 4t5l4t8473, 132449-89-9 (lesopitron hcl), Pyrimidine, 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)-, dihydrochloride

Molecular Formula

C₁₅H₂₃Cl₃N₆

Molecular Weight

393.7 g/mol

InChI Key

RGDLQJUAYQRGBC-UHFFFAOYSA-N

FDA UNII

4T5L4T8473

1 2D Structure

Lesopitron Dihydrochloride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine;dihydrochloride

2.1.2 InChI

InChI=1S/C15H21ClN6.2ClH/c16-14-12-19-22(13-14)7-2-1-6-20-8-10-21(11-9-20)15-17-4-3-5-18-15;;/h3-5,12-13H,1-2,6-11H2;2*1H

2.1.3 InChI Key

RGDLQJUAYQRGBC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CN(CCN1CCCCN2C=C(C=N2)Cl)C3=NC=CC=N3.Cl.Cl

2.2 Other Identifiers

2.2.1 UNII

4T5L4T8473

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 2-(4-(4-(4-chloro-1-pyrazolyl)butyl)-1-piperazinyl)pyrimidine

2. E 4424

3. E-4424

4. E4424

5. Lesopitron

2.3.2 Depositor-Supplied Synonyms

1. 132449-89-9

2. Lesopitron (dihydrochloride)

3. E-4424

4. 4t5l4t8473

5. 132449-89-9 (lesopitron Hcl)

6. Pyrimidine, 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)-, Dihydrochloride

7. 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)piperazin-1-yl)pyrimidine Dihydrochloride

8. Unii-4t5l4t8473

9. E 4424

10. 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)pyrimidine Dihydrochloride

11. Schembl1822413

12. Dtxsid00157588

13. Cs-6845

14. Lesopitron Dihydrochloride [mi]

15. Hy-101609

16. Q27260460

17. 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine;dihydrochloride

18. Pyrimidine, 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:2)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₂₃Cl₃N₆
Molecular Weight	393.7 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	6
Exact Mass	392.104978 g/mol
Monoisotopic Mass	392.104978 g/mol
Topological Polar Surface Area	50.1 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	317
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3